iHuman Inc【IH】株式ニュース

iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect LingoMay 31, 2026 12:03 PM
PR Newswire (US) BEIJING, May 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it has entered into certain asset transfer agreements to acquire the businesses and assets related to two products, All Knowledge (???) and Perfect Lingo (???) (the "Acquisitions"), for an aggregate consideration of RMB94.0 million, subject to potential two-way price adjustments and contingent earn-out payments. All Knowledge is an app that focuses on humanities and AI literacy, providing users with AI-powered interactive access to knowledge across history, culture, literature, philosophy, art, and other humanities fields. All Knowledge features a number of systematic learning tools, including spatio-temporal views, historical timelines, and relationship graphs. It has also launched a series of ladder-style learning products, including Elite Youth Tianti, which is among China's first batch of systematic general knowledge learning programs, Literature and History Tianti, which provides comprehensive and structured learning content for literature and history enthusiasts, and AI Tianti, which is designed to help users better apply, understand, and harness AI.Perfect Lingo is an AI learning app designed to help users expand their vocabulary, improve pronunciation, and develop comprehensive English learning capabilities through real-life scenarios and video-based learning, extensive dictionaries, AI-powered assessment, intensive training exercises, and pronunciation practice, as well as a personalized AI learning system built around vocabulary learning.Mr. Michael Yufeng Chi, founder and chairman of iHuman, commented, "We are pleased to announce the acquisition of the businesses and assets related to All Knowledge and Perfect Lingo. The Acquisitions represent not only an important step in expanding our product portfolio, but also a strategically meaningful move for us in the industry. All Knowledge and Perfect Lingo bring strong content, AI technology capabilities, deep understanding of the learning market across all age groups, and proven organizational execution in sales and services. All Knowledge and Perfect Lingo are highly complementary to our existing product ecosystem, and will open up new market opportunities for us. The addition of these products will also help us extend the boundaries of our services and the user groups we reach, while further expanding our product portfolio and AI capabilities, deepening our content offerings, diversifying our product ecosystem, and generating stronger synergies across our products. We believe this initiative will significantly enhance our market competitiveness and unlock substantial potential for future growth.In addition, on behalf of the board of directors, I am pleased to announce the appointment of Mr. Teng Li from All Knowledge and Perfect Lingo as Co-Chief Executive Officer (Co-CEO) of iHuman, effective upon closing of the transactions. We are also pleased to welcome Ms. Congyu Lin as our new Chief Strategy Officer (CSO) to support the Company's business development. Prior to joining iHuman, Ms. Congyu Lin held the position of Senior Vice President at Perfect World, and will bring her extensive experience in management and strategic planning to us. Mr. Li and Ms. Lin have each demonstrated outstanding leadership and deep expertise in their respective fields. Their addition will bring fresh energy and strategic vision to iHuman. We believe they will work closely with our existing management team to further drive the Company's business development, open up broader market opportunities, and create more sustainable growth momentum," Mr. Chi concluded.Pursuant to the asset transfer agreements, the Company will conduct acquisition of the businesses and assets related to All Knowledge and Perfect Lingo, for considerations of RMB67.0 million and RMB27.0 million, respectively, subject to potential purchase price adjustments. The purchase prices would be adjusted downward to RMB51.0 million for All Knowledge and RMB21.0 million for Perfect Lingo if certain material adverse events occur. In addition, the sellers may be entitled to contingent earn-out payments of up to RMB29.0 million for All Knowledge and RMB12.0 million for Perfect Lingo in cash, subject to the achievement of certain financial conditions over the next three years. The Company engaged the valuation services of a "Big Four" accounting firm (the "Valuer") to prepare an independent third-party valuation. The considerations were determined with the assistance of the Valuer. The Acquisitions, which constitute related party transactions due to the common control between the transferors and the Company, have been approved by the board of directors and the audit committee and are subject to customary closing conditions. The appointments of Mr. Teng Li and Ms. Congyu Lin have also been nominated by the Company's nominating and corporate governance committee and approved by the board of directors.Safe Harbor StatementThis announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.About iHuman Inc. iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.For investor and media enquiries, please contact:iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86-10-5780-6606
E-mail: ir@ihuman.comChristensen Advisory
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: ihumangroup@christensencomms.com View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-acquisition-of-businesses-and-assets-related-to-all-knowledge-and-perfect-lingo-302786467.htmlSOURCE iHuman Inc. Original: iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial ResultsMarch 31, 2026 6:06 AM
PR Newswire (US)

BEIJING, March 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025.

Fourth Quarter 2025 HighlightsRevenues were RMB190.7 million (US$27.3 million), compared with RMB232.7 million in the same period last year.Gross profit was RMB127.5 million (US$18.2 million), compared with RMB156.4 million in the same period last year.Operating income was RMB9.0 million (US$1.3 million), compared with RMB14.9 million in the same period last year.Net income was RMB15.4 million (US$2.2 million), compared with RMB26.5 million in the same period last year.Average total MAUs[1] for the fourth quarter were 23.57 million, compared with 25.78 million in the same period last year.Fiscal Year 2025 HighlightsRevenues were RMB807.0 million (US$115.4 million), compared with RMB922.2 million in fiscal year 2024.Gross profit was RMB547.6 million (US$78.3 million), compared with RMB640.2 million in fiscal year 2024.Operating income was RMB66.8 million (US$9.5 million), compared with RMB71.9 million in fiscal year 2024.Net income was RMB95.4 million (US$13.6 million), compared with RMB98.6 million in fiscal year 2024.Average total MAUs were 24.98 million, compared with 26.47 million in fiscal year 2024.[1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "During the fourth quarter, we effectively executed our key strategic initiatives, maintaining operational resilience amid a complex environment. As shifting demographic trends reshape the childhood education landscape, we have proactively evolved our product portfolio to ensure long-term sustainability.A cornerstone of this evolution is our strategic expansion into broader user segments. In the fourth quarter, we launched FreeTalk, an AI-native oral English application designed for a broad spectrum of learners seeking to improve their spoken English across general, academic, and professional contexts. By providing on-demand access to highly realistic AI-powered digital tutors, FreeTalk effectively lowers the barriers to mastering spoken English while creating a flexible, judgment-free environment that helps mitigate speaking anxiety. At the same time, the app allows users to progress through structured learning materials at their own pace and tailor learning content to their individual needs, significantly improving learning efficiency. Powered by advanced speech recognition and generative AI, the platform helps strengthen overall English communication skills by delivering immersive, guided dialogue with real-time adaptive feedback, helping learners refine their pronunciation, fluency, grammar, and vocabulary across a wide range of real-world scenarios. The launch of FreeTalk marks a significant milestone in our strategic expansion beyond childhood education, broadening our total addressable market, extending the user lifecycle, and diversifying our long-term growth opportunities.Alongside these initiatives, we continued to drive product innovation across our core offerings. Within iHuman Chinese, we introduced a new interactive "Animal Park" module designed around an innovative learning cycle that combines knowledge discovery with built-in review. Children can unlock different animals as they master new Chinese characters, while reinforcement is seamlessly embedded into frequent, engaging interactions such as feeding and cleaning. By integrating literacy learning with edutainment-driven progression, the module adds elements of joy and motivation that enhance engagement and reinforce learning outcomes. We also expanded our smart device portfolio with iHuman AI Bilingual Early Learning Tablet. This device offers families a secure, one-stop learning solution that integrates our comprehensive content ecosystem of stories, animations, songs, and interactive activities. In addition, the tablet features certified eye-protection capabilities and a child-friendly form factor, promoting healthy usage habits while fostering a genuine love of learning.Our Kunpeng Animation Studio continued to make steady progress in advancing our original animation content and IP. Building on the success of the first Cosmicrew movie, we recently launched the franchise's second installment Ice Planet, further strengthening its presence among young audiences. To complement the movie's theatrical screenings, we organized a series of offline fan engagement activities, creating opportunities for children to interact directly with the characters. These in-person experiences extended engagement beyond the screen, deepening audience connection and brand affinity.Looking into 2026, we will continue to execute with focus and discipline, advancing our product innovation, content strength, and technology to further enhance user experience and learning effectiveness. While navigating an evolving environment, we remain committed to prudent operations and long-term sustainability, with the aim of creating enduring value for users and shareholders."Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "During the quarter, we made solid progress in our international expansion with our global offerings gaining broader market recognition. Aha World, our open-ended, creativity-driven digital world designed to encourage exploration and imagination, delivered particularly strong performance. From Thanksgiving through the New Year period, daily active users (DAUs) on the U.S. Apple App Store increased by approximately 30%, highlighting the product's growing appeal in the largest overseas market and its long-term growth potential. In addition, Reading Stars, the innovative reading product we developed in collaboration with Cricket Media, has quickly gained industry recognition for its high-quality content and innovative design. The product was recently honored with both the U.S. National Parenting Product Awards (NAPPA) and the Mom's Choice Awards (MCA), demonstrating the strong endorsement of our products by the U.S. market.Reflecting our confidence in the business and commitment to shareholder returns, our board of directors has approved a special cash dividend of US$0.02 per ordinary share, or US$0.10 per American Depositary Share (ADS), totaling approximately US$5.1 million. This marks the third consecutive year in which we have declared a special cash dividend, reflecting the structural sustainability of our financial performance.Looking ahead, we are encouraged by our resilient business performance and believe our differentiated, content-driven portfolio positions us well to continue building our global presence and creating long-term value."Fourth Quarter 2025 Unaudited Financial ResultsRevenuesRevenues were RMB190.7 million (US$27.3 million), compared with RMB232.7 million in the same period last year. The decrease in revenues was primarily due to the decline in China's newborn population and more conservative consumer spending.Average total MAUs for the quarter were 23.57 million, compared with 25.78 million in the same period last year. The decrease in MAUs was primarily due to the decline in China's newborn population.Cost of RevenuesCost of revenues was RMB63.2 million (US$9.0 million), compared with RMB76.2 million in the same period last year. The decline in cost of revenues was in line with the decrease in revenues.Gross Profit and Gross MarginGross profit was RMB127.5 million (US$18.2 million), compared with RMB156.4 million in the same period last year. Gross margin was 66.9%, compared with 67.2% in the same period last year.Operating ExpensesTotal operating expenses were RMB118.5 million (US$16.9 million), a decrease of 16.3% from RMB141.5 million in the same period last year.Research and development expenses were RMB44.9 million (US$6.4 million), a decrease of 29.0% from RMB63.3 million in the same period last year, primarily due to savings in payroll-related expenses.Sales and marketing expenses were RMB52.7 million (US$7.5 million), compared with RMB54.1 million in the same period last year.General and administrative expenses were RMB20.8 million (US$3.0 million), a decrease of 13.7% from RMB24.1 million in the same period last year, primarily due to savings in payroll-related and other administrative expenses.Operating Income Operating income was RMB9.0 million (US$1.3 million), compared with RMB14.9 million in the same period last year.Net Income Net income was RMB15.4 million (US$2.2 million), compared with RMB26.5 million in the same period last year.Basic and diluted net income per ADS were RMB0.30 (US$0.04) and RMB0.29 (US$0.04), respectively, compared with RMB0.51 and RMB0.49 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.Deferred Revenue and Customer AdvancesDeferred revenue and customer advances were RMB219.9 million (US$31.4 million) as of December 31, 2025, compared with RMB283.3 million as of December 31, 2024.Cash, Cash Equivalents and Short-term InvestmentsCash, cash equivalents and short-term investments were RMB1,151.1 million (US$164.6 million) as of December 31, 2025, compared with RMB1,168.7 million as of December 31, 2024.Fiscal Year 2025 Unaudited Financial ResultsRevenuesRevenues were RMB807.0 million (US$115.4 million), compared with RMB922.2 million in fiscal year 2024. The decrease in revenues was primarily due to the decline in China's newborn population and more conservative consumer spending.Average total MAUs were 24.98 million, compared with 26.47 million in fiscal year 2024. The decrease in MAUs was primarily due to the decline in China's newborn population.Cost of RevenuesCost of revenues was RMB259.4 million (US$37.1 million), compared with RMB282.0 million in fiscal year 2024. The decline in cost of revenues was in line with the decrease in revenues.Gross Profit and Gross MarginGross profit was RMB547.6 million (US$78.3 million), compared with RMB640.2 million in fiscal year 2024. Gross margin was 67.9%, compared with 69.4% in fiscal year 2024. The decrease in gross margin was mainly due to the diversification and structural upgrades of the Company's product portfolio.Operating ExpensesTotal operating expenses were RMB480.9 million (US$68.8 million), a decrease of 15.4% from RMB568.2 million in fiscal year 2024.Research and development expenses were RMB208.4 million (US$29.8 million), a decrease of 15.9% from RMB247.8 million in fiscal year 2024, primarily due to savings in payroll-related expenses.Sales and marketing expenses were RMB181.0 million (US$25.9 million), a decrease of 18.2% from RMB221.2 million in fiscal year 2024, primarily due to cost savings in marketing activities.General and administrative expenses were RMB91.4 million (US$13.1 million), a decrease of 7.9% from RMB99.3 million in fiscal year 2024, primarily due to savings in payroll-related and other administrative expenses.Operating IncomeOperating income was RMB66.8 million (US$9.5 million), compared with RMB71.9 million in fiscal year 2024.Net Income Net income was RMB95.4 million (US$13.6 million), compared with RMB98.6 million in fiscal year 2024.Basic and diluted net income per ADS were RMB1.86 (US$0.27) and RMB1.78 (US$0.25), respectively, compared with RMB1.88 and RMB1.82 in fiscal year 2024. Each ADS represents five Class A ordinary shares of the Company.Special Cash DividendTo deliver return of capital to shareholders, the Company's board of directors (the "Board") approved a special cash dividend of US$0.02 per ordinary share, or US$0.10 per ADS, to holders of ordinary shares and holders of ADSs as of the close of business on April 17, 2026 New York Time, payable in U.S. dollars. The aggregate amount of the special dividend will be approximately US$5.1 million. The payment date is expected to be on or around May 8, 2026 and May 15, 2026 for holders of ordinary shares and holders of ADSs, respectively.Exchange Rate InformationThe U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of December 31, 2025, which was RMB6.9931 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.Non-GAAP Financial MeasuresiHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.Safe Harbor StatementThis announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.About iHuman Inc.iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.For more information about iHuman, please visit: https://ir.ihuman.com/For investor and media enquiries, please contact:iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86-10-5780-6606
E-mail: ir@ihuman.comChristensen Advisory
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: ihumangroup@christensencomms.com   iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")except for number of shares, ADSs, per share and per ADS data)

December 31,
December 31,
December 31,
2024
2025
2025
RMB
RMB
US$

ASSETS

Current assets

Cash and cash equivalents 1,123,292
1,151,120
164,608Short-term investments45,457
-
-Accounts receivable, net 52,030
47,070
6,731Inventories, net23,475
21,388
3,058Amounts due from related parties2,051
4,314
617Prepayments and other current assets89,512
74,483
10,651Total current assets 1,335,817
1,298,375
185,665Non-current assets

Property and equipment, net3,476
2,563
367Intangible assets, net16,429
17,634
2,522Operating lease right-of-use assets14,885
11,586
1,657Long-term investment26,333
26,333
3,766Other non-current assets22,701
11,864
1,696Total non-current assets83,824
69,980
10,008Total assets 1,419,641
1,368,355
195,673

LIABILITIES

Current liabilities

Accounts payable30,233
25,083
3,587Deferred revenue and customer advances283,251
219,913
31,447Amounts due to related parties1,734
1,066
152Accrued expenses and other current liabilities126,501
115,749
16,552Dividend payable2,164
-
-Current operating lease liabilities3,661
2,166
310Total current liabilities447,544
363,977
52,048Non-current liabilities

Non-current operating lease liabilities11,252
9,208
1,317Total non-current liabilities11,252
9,208
1,317Total liabilities 458,796
373,185
53,365SHAREHOLDERS' EQUITY

Ordinary shares (par value of US$0.0001 per share, 700,000,000 Class A shares authorized as of December 31, 2024 and December 31, 2025; 125,122,382 Class A shares issued and 116,084,207 outstanding as of December 31, 2024; 125,122,382 Class A shares issued and 111,541,887 outstanding as of December 31, 2025; 200,000,000 Class B shares authorized, 144,000,000 Class B ordinary shares issued and outstanding as of December 31, 2024 and December 31, 2025; 100,000,000 shares (undesignated) authorized, nil shares (undesignated) issued and outstanding as of December 31, 2024 and December 31, 2025)185
186
27Additional paid-in capital996,657
960,641
137,370Treasury stock(26,296)
(43,483)
(6,218)Statutory reserves8,395
8,463
1,210Accumulated other comprehensive income 24,009
16,134
2,307Retained earnings (accumulated deficit)(42,105)
53,229
7,612Total shareholders' equity960,845
995,170
142,308Total liabilities and shareholders' equity1,419,641
1,368,355
195,673  iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")except for number of shares, ADSs, per share and per ADS data)

For the three months ended
For the year ended
December 31,
September 30,
December 31,
December 31,
December 31,
December 31,
December 31,
2024
2025
2025
2025
2024
2025
2025
RMB
RMB
RMB
US$
RMB
RMB
US$

Revenues232,684
205,764
190,654
27,263
922,201
807,019
115,402Cost of revenues(76,243)
(65,134)
(63,198)
(9,037)
(282,048)
(259,409)
(37,095)

Gross profit 156,441
140,630
127,456
18,226
640,153
547,610
78,307

Operating expenses

Research and development expenses(63,308)
(55,294)
(44,930)
(6,425)
(247,757)
(208,443)
(29,807)Sales and marketing expenses(54,109)
(45,720)
(52,715)
(7,538)
(221,230)
(180,969)
(25,878)General and administrative expenses(24,106)
(22,949)
(20,808)
(2,976)
(99,254)
(91,442)
(13,076)Total operating expenses (141,523)
(123,963)
(118,453)
(16,939)
(568,241)
(480,854)
(68,761)Operating income14,918
16,667
9,003
1,287
71,912
66,756
9,546Other income, net12,245
5,318
6,941
993
38,689
35,033
5,010Income before income taxes27,163
21,985
15,944
2,280
110,601
101,789
14,556Income tax expenses (682)
(400)
(534)
(76)
(12,012)
(6,387)
(913)Net income26,481
21,585
15,410
2,204
98,589
95,402
13,643

Net income per ADS:

   - Basic0.51
0.42
0.30
0.04
1.88
1.86
0.27   - Diluted0.49
0.40
0.29
0.04
1.82
1.78
0.25

Weighted average number of ADSs:

   - Basic52,097,127
51,201,957
51,105,266
51,105,266
52,400,383
51,395,037
51,395,037   - Diluted53,965,183
53,434,919
53,305,240
53,305,240
54,239,751
53,522,994
53,522,994

Total share-based compensation expenses included in:

Cost of revenues18
8
6
1
106
31
4Research and development expenses 273
87
98
14
1,303
362
52Sales and marketing expenses 34
16
14
2
164
62
9General and administrative expenses 229
85
83
12
1,251
267
38  iHuman Inc.
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS
(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")except for number of shares, ADSs, per share and per ADS data)

For the three months ended
For the year ended
December 31,
September 30,
December 31,
December 31,
December 31,
December 31,
December 31,
2024
2025
2025
2025
2024
2025
2025
RMB
RMB
RMB
US$
RMB
RMB
US$

Operating income14,918
16,667
9,003
1,287
71,912
66,756
9,546Share-based compensation expenses554
196
201
29
2,824
722
103Adjusted operating income15,472
16,863
9,204
1,316
74,736
67,478
9,649

Net income26,481
21,585
15,410
2,204
98,589
95,402
13,643Share-based compensation expenses554
196
201
29
2,824
722
103Adjusted net income27,035
21,781
15,611
2,233
101,413
96,124
13,746

Diluted net income per ADS0.49
0.40
0.29
0.04
1.82
1.78
0.25Impact of non-GAAP adjustments 0.01
0.01
0.00
0.00
0.05
0.02
0.01Adjusted diluted net income per ADS 0.50
0.41
0.29
0.04
1.87
1.80
0.26

Weighted average number of ADSs – diluted53,965,183
53,434,919
53,305,240
53,305,240
54,239,751
53,522,994
53,522,994Weighted average number of ADSs – adjusted53,965,183
53,434,919
53,305,240
53,305,240
54,239,751
53,522,994
53,522,994

View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-fourth-quarter-and-fiscal-year-2025-unaudited-financial-results-302729823.htmlSOURCE iHuman Inc.

Original: iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results